Provided by Tiger Trade Technology Pte. Ltd.

Solid Biosciences

7.11
-0.6200-8.02%
Post-market: 7.210.1000+1.41%18:13 EDT
Volume:826.55K
Turnover:5.98M
Market Cap:699.56M
PE:-3.57
High:7.92
Open:7.73
Low:7.05
Close:7.73
52wk High:8.72
52wk Low:2.41
Shares:98.39M
Float Shares:58.54M
Volume Ratio:0.81
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9922
EPS(LYR):-3.0550
ROE:-109.90%
ROA:-53.18%
PB:3.89
PE(LYR):-2.33

Loading ...

Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2025

Major Issues Report

Form 8-K - Current report
Aug 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 13, 2025

Major Issues Report

Form 8-K - Current report
Jun 13, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 23, 2025

Correspondence

Form CORRESP - Correspondence
May 15, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 12, 2025

Correspondence

Form CORRESP - Correspondence
Mar 12, 2025

Correspondence

Form CORRESP - Correspondence
Mar 06, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 06, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 19, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses